Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 17 | 2022 | 98 | 3.300 |
Why?
|
| Atrial Appendage | 5 | 2022 | 27 | 1.800 |
Why?
|
| Catheter Ablation | 12 | 2021 | 37 | 1.680 |
Why?
|
| Pacemaker, Artificial | 6 | 2022 | 11 | 0.990 |
Why?
|
| Cardiac Pacing, Artificial | 7 | 2022 | 13 | 0.920 |
Why?
|
| Pulmonary Veins | 5 | 2020 | 10 | 0.830 |
Why?
|
| Stroke | 4 | 2022 | 244 | 0.720 |
Why?
|
| Cardiac Catheterization | 2 | 2018 | 55 | 0.720 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2020 | 58 | 0.680 |
Why?
|
| Heart Transplantation | 1 | 2018 | 29 | 0.590 |
Why?
|
| Bundle of His | 4 | 2022 | 4 | 0.550 |
Why?
|
| Cryosurgery | 3 | 2020 | 16 | 0.500 |
Why?
|
| Treatment Outcome | 13 | 2022 | 3093 | 0.470 |
Why?
|
| Heart Failure | 3 | 2020 | 141 | 0.430 |
Why?
|
| Humans | 34 | 2022 | 23541 | 0.400 |
Why?
|
| Electric Injuries | 1 | 2011 | 1 | 0.360 |
Why?
|
| Intercostal Muscles | 1 | 2011 | 3 | 0.360 |
Why?
|
| Spasm | 1 | 2011 | 2 | 0.360 |
Why?
|
| Transposition of Great Vessels | 2 | 2008 | 2 | 0.320 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2018 | 32 | 0.300 |
Why?
|
| Heart Defects, Congenital | 1 | 2008 | 22 | 0.290 |
Why?
|
| Risk Factors | 8 | 2022 | 1997 | 0.290 |
Why?
|
| Defibrillators, Implantable | 2 | 2018 | 10 | 0.270 |
Why?
|
| Heart Rate | 4 | 2020 | 104 | 0.260 |
Why?
|
| Male | 17 | 2021 | 12743 | 0.260 |
Why?
|
| Aged | 12 | 2021 | 7572 | 0.250 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2021 | 27 | 0.240 |
Why?
|
| Electric Countershock | 1 | 2005 | 9 | 0.240 |
Why?
|
| Thrombosis | 2 | 2018 | 52 | 0.230 |
Why?
|
| Registries | 3 | 2021 | 179 | 0.230 |
Why?
|
| Action Potentials | 3 | 2020 | 82 | 0.220 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2021 | 4 | 0.220 |
Why?
|
| Heart Ventricles | 2 | 2022 | 84 | 0.220 |
Why?
|
| Anticoagulants | 2 | 2018 | 84 | 0.200 |
Why?
|
| Prosthesis Implantation | 2 | 2016 | 26 | 0.200 |
Why?
|
| Electrocoagulation | 1 | 2022 | 8 | 0.190 |
Why?
|
| Risk Assessment | 5 | 2020 | 555 | 0.190 |
Why?
|
| Equipment Design | 2 | 2021 | 122 | 0.190 |
Why?
|
| Atrial Flutter | 3 | 2011 | 4 | 0.190 |
Why?
|
| Time Factors | 6 | 2021 | 1293 | 0.180 |
Why?
|
| Bradycardia | 1 | 2021 | 22 | 0.180 |
Why?
|
| Middle Aged | 12 | 2020 | 8134 | 0.180 |
Why?
|
| Metabolic Equivalent | 1 | 2020 | 2 | 0.170 |
Why?
|
| Septal Occluder Device | 1 | 2020 | 6 | 0.170 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 30 | 0.170 |
Why?
|
| Retrospective Studies | 8 | 2021 | 3122 | 0.170 |
Why?
|
| Radiation Exposure | 1 | 2020 | 5 | 0.160 |
Why?
|
| Radiography, Interventional | 1 | 2020 | 12 | 0.160 |
Why?
|
| Adult | 7 | 2021 | 7168 | 0.160 |
Why?
|
| Radiation Dosage | 1 | 2020 | 35 | 0.160 |
Why?
|
| Ventricular Premature Complexes | 1 | 2019 | 2 | 0.160 |
Why?
|
| Heparin Antagonists | 1 | 2019 | 1 | 0.160 |
Why?
|
| Protamines | 1 | 2019 | 3 | 0.160 |
Why?
|
| Hemostasis | 1 | 2019 | 11 | 0.160 |
Why?
|
| Female | 14 | 2021 | 13239 | 0.160 |
Why?
|
| Heparin | 1 | 2019 | 22 | 0.160 |
Why?
|
| Hemorrhage | 1 | 2019 | 74 | 0.150 |
Why?
|
| Suture Techniques | 1 | 2019 | 117 | 0.150 |
Why?
|
| Punctures | 1 | 2018 | 10 | 0.150 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 27 | 0.150 |
Why?
|
| Image Enhancement | 1 | 2018 | 44 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 39 | 0.150 |
Why?
|
| Contrast Media | 1 | 2018 | 60 | 0.150 |
Why?
|
| Electrodes, Implanted | 2 | 2008 | 22 | 0.150 |
Why?
|
| Bundle-Branch Block | 1 | 2018 | 4 | 0.150 |
Why?
|
| Ventricular Fibrillation | 2 | 2016 | 13 | 0.140 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 1 | 0.140 |
Why?
|
| Computer Security | 1 | 2018 | 6 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2018 | 59 | 0.140 |
Why?
|
| Policy Making | 1 | 2017 | 12 | 0.140 |
Why?
|
| Azygos Vein | 1 | 2017 | 3 | 0.140 |
Why?
|
| Vena Cava, Inferior | 1 | 2017 | 9 | 0.140 |
Why?
|
| Incidental Findings | 1 | 2017 | 12 | 0.140 |
Why?
|
| Recurrence | 4 | 2020 | 276 | 0.140 |
Why?
|
| Consensus | 1 | 2017 | 85 | 0.130 |
Why?
|
| Cardiology | 1 | 2017 | 45 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2017 | 119 | 0.130 |
Why?
|
| Exercise | 1 | 2020 | 400 | 0.130 |
Why?
|
| Intraoperative Care | 1 | 2016 | 41 | 0.120 |
Why?
|
| Electrocardiography | 3 | 2022 | 93 | 0.100 |
Why?
|
| Heart Atria | 1 | 2011 | 24 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2011 | 9 | 0.090 |
Why?
|
| Stroke Volume | 2 | 2021 | 43 | 0.090 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2010 | 10 | 0.080 |
Why?
|
| Telemetry | 1 | 2010 | 7 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2021 | 209 | 0.080 |
Why?
|
| Ischemic Attack, Transient | 1 | 2010 | 16 | 0.080 |
Why?
|
| Coronary Occlusion | 1 | 2010 | 1 | 0.080 |
Why?
|
| Fluoroscopy | 2 | 2020 | 35 | 0.080 |
Why?
|
| Exercise Test | 2 | 2020 | 112 | 0.080 |
Why?
|
| Coronary Angiography | 2 | 2010 | 68 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 1 | 2009 | 20 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2009 | 24 | 0.080 |
Why?
|
| Brain Ischemia | 1 | 2010 | 61 | 0.080 |
Why?
|
| Cardiac Electrophysiology | 1 | 2008 | 2 | 0.080 |
Why?
|
| Iliac Vein | 1 | 2008 | 3 | 0.070 |
Why?
|
| Equipment Failure | 1 | 2008 | 35 | 0.070 |
Why?
|
| Pericardium | 1 | 2008 | 20 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 3767 | 0.070 |
Why?
|
| Torsades de Pointes | 1 | 2007 | 7 | 0.070 |
Why?
|
| Long QT Syndrome | 1 | 2007 | 5 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2020 | 1532 | 0.060 |
Why?
|
| Amiodarone | 1 | 2005 | 3 | 0.060 |
Why?
|
| International Normalized Ratio | 1 | 2005 | 18 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 36 | 0.060 |
Why?
|
| Warfarin | 1 | 2005 | 25 | 0.060 |
Why?
|
| United States | 2 | 2019 | 1837 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 293 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2022 | 6 | 0.050 |
Why?
|
| Thermography | 1 | 2021 | 8 | 0.040 |
Why?
|
| Temperature | 1 | 2021 | 58 | 0.040 |
Why?
|
| Swine | 1 | 2021 | 68 | 0.040 |
Why?
|
| Therapeutic Irrigation | 1 | 2021 | 48 | 0.040 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 3 | 0.040 |
Why?
|
| Hyperthyroidism | 1 | 2020 | 10 | 0.040 |
Why?
|
| Heart Valve Diseases | 1 | 2020 | 11 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2020 | 8 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 254 | 0.040 |
Why?
|
| Lasers | 1 | 2020 | 14 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 172 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 38 | 0.040 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 52 | 0.040 |
Why?
|
| Alcoholism | 1 | 2020 | 65 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 43 | 0.040 |
Why?
|
| Hemostatic Techniques | 1 | 2019 | 6 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2020 | 132 | 0.040 |
Why?
|
| Hypertension | 1 | 2020 | 163 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 379 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 124 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 530 | 0.040 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2018 | 3 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 324 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 648 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 644 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 294 | 0.030 |
Why?
|
| Phlebography | 1 | 2017 | 9 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 27 | 0.030 |
Why?
|
| Myocardial Infarction | 2 | 2010 | 126 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 603 | 0.030 |
Why?
|
| Reoperation | 1 | 2020 | 767 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 1745 | 0.030 |
Why?
|
| Animals | 1 | 2021 | 3293 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 453 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 51 | 0.020 |
Why?
|
| Epicardial Mapping | 1 | 2009 | 2 | 0.020 |
Why?
|
| Autopsy | 1 | 2010 | 257 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 443 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2010 | 39 | 0.020 |
Why?
|
| Hospitalization | 1 | 2010 | 292 | 0.020 |
Why?
|
| Chicago | 1 | 2010 | 818 | 0.020 |
Why?
|
| Adolescent | 1 | 2009 | 1952 | 0.010 |
Why?
|
| Length of Stay | 1 | 2005 | 305 | 0.010 |
Why?
|